Our demonstration that synthetic agonists of GPR84 activate pro-inflammatory signaling and cytokine release in already activated macrophage populations suggests that detailed examination of GPR84 expression and signaling is merited in murine and human atherosclerosis. This evidence concerns the gene GPR84 and atherosclerosis.